PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population

NCT05043740 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

1360

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Repatha or Praluent

Sponsor

Second Xiangya Hospital of Central South University